Evidence map›Paper›PMID 36091864›Full record

ArticleHerald of the Russian Academy of Sciences2022

COVID-19 Pandemic and Cardiovascular Diseases: Lessons and Prospects.

E V Shlyakhto, A O Konradi, T L Karonova, P A Fedotov

Open access · bronzeAbstract read
In one paragraph

Article in Herald of the Russian Academy of Sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

E V ShlyakhtoAlmazov National Medical Research Center, Ministry of Health of Russia, St. Petersburg, Russia.
A O KonradiAlmazov National Medical Research Center, Ministry of Health of Russia, St. Petersburg, Russia.
T L KaronovaAlmazov National Medical Research Center, Ministry of Health of Russia, St. Petersburg, Russia.
P A FedotovAlmazov National Medical Research Center, Ministry of Health of Russia, St. Petersburg, Russia.
Federal Almazov North-West Medical Research Centre · RUMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is focused on the topicality of assessing complications and mortality from diseases of the circulatory system during the COVID-19 pandemic. The main variants of damage to the cardiovascular system, the mechanisms of their development, and risk factors are given. The long-term consequences of the new coronavirus infection for the heart and blood vessels are considered. In addition, the necessary measures to reduce the burden of disease after the pandemic are discussed.

Indexed as

chronic heart failurecirculatory system diseasescoronavirus infectionheart transplantationmyocarditis

Identifiers

PMID36091864
PMCPMC9447940
OpenAlexW4294838381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.